Currently, few functional studies have focused on SPOCK2, which showed that SPOCK2 was associated with lung adenocarcinoma [18], prostate cancer [19], ovarian cancer [20], and bronchopulmonary dysplasia [21]. Here, SPOCK2 is linked to prostate cancer.